Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis

Area of Science:

• Medical Research
• Genetics
• Public Health

Background:

• Hereditary hemochromatosis (HH) research suggests screening may be cost-effective.
• Low-cost treatments exist for homozygous individuals, but disease penetrance and irreversible complications pose challenges.

Purpose of the Study:

• To evaluate the cost-effectiveness of a screening strategy for hereditary hemochromatosis.
• To assess the efficacy of early intervention through phlebotomy before irreversible complications arise.

Main Methods:

• Review of existing research and practice guidelines.
• Cost-effectiveness analysis of a proposed screening strategy.
• Inclusion of transferrin saturation, ferritin testing, and liver biopsy in diagnostic pathways.

Main Results:

• Screening for HH is supported by significant research.
• Guidelines recommend specific tests and lifelong phlebotomy for affected individuals.
• The study evaluates the healthcare goals achievable through a screening strategy.

Conclusions:

• A hereditary hemochromatosis screening strategy shows potential for cost-effectiveness.
• Timely intervention is crucial to prevent irreversible disease complications.
• Further analysis is presented on the efficacy of this screening approach.